Vienna, Austria

ESTRO 2023

Session Item

Saturday
May 13
16:45 - 17:45
Business Suite 1-2
Technical improvements in radiotherapy practice
Rianne de Jong, The Netherlands
Poster Discussion
RTT
Audit of prostate cancer planning CT rescan rate and value
Sophie Alexander, United Kingdom
PD-0312

Abstract

Audit of prostate cancer planning CT rescan rate and value
Authors:

Sophie Alexander1, Helen.A. McNair1, Uwe Oelfke2, Clare Ockwell3, Alison.C. Tree4

1The Royal Marsden NHS Foundation Trust/ The Institute of Cancer Research, Radiotherapy, Sutton, United Kingdom; 2The Royal Marsden NHS Foundation Trust/ The Institute of Cancer Research, Joint department of physics, Sutton, United Kingdom; 3The Royal Marsden NHS Foundation Trust, Radiotherapy, Sutton, United Kingdom; 4The Royal Marsden NHS Foundation Trust/ The Institute of Cancer Research, Uro-Oncology, Sutton, United Kingdom

Show Affiliations
Purpose or Objective

UK radiotherapy guidance recommends instigating a repeat planning CT (pCT) scan for prostate cancer (PCa) patients with a rectal diameter (RD) >4cm[1]. Additional bowel preparation, diet or voiding instruction are typically given for this. But are these diameter restrictions achievable on pCT and during radiotherapy?

Material and Methods

From March-May 2021 inclusive, the number of radical PCa radiotherapy patients requiring a rescan was audited. All patients used micro-enemas 2-days and 1.5-hours prior to pCT. Rescan (on another day with additional micro-enemas) was initiated if RD, measured on an 8-slice short series (SS) pCT over the pubic symphysis (ps), was >4.5cm anterior-posterior (AP) and 3cm left-right (LR).

An experienced RTT retrospectively measured RD for the rescan group plus a matched control group (patients not requiring rescan). Maximum RD, AP and LR, was measured on the SS, pCT and cone-beam CT (CBCT) images from all fractions. Measurements were taken at 3 levels: superior aspect, inferior aspect and mid-point of ps.

RD differences between groups and for different schedules was compared.

Results

175 PCa patients underwent a pCT during this time, 22 (13%) required a rescan. 18/22 patients had CBCT imaging at every fraction (#), these were reviewed further. In the rescan group, four different fractionations were prescribed; 36Gy in 6#’s (n=8), 60Gy in 20#’s (n=8), 57Gy in 19#’s (n=1) and 36.25Gy in 5#’s (n=1). Control group patients were matched by radiotherapy schedule.

Mean RD was larger and more variable in the rescan group (Figure 1). Difference in mean RD in the rescan group (across all measurement points) was AP/LR respectively: -0.36/-0.36cm from SS to pCT, -0.24/-0.14cm from pCT to CBCT and -0.59/-0.50cm from SS to CBCT. The control group RD difference AP/LR was smaller: +0.15/+0.16cm from SS to pCT, -0.03/0.08cm from pCT to CBCT and +0.13/+0.07cm from SS to CBCT.


Rectum visualisation was clearest at the superior-ps position, change in RD for 6 and 20# schedules was compared as this point (Figure 2).

6# rescan group: Mean RD was larger than the control for all timepoints and >4cm in at least 1 direction for all bar #1. CBCT RD was larger than pCT for 4#’s AP and 5#’s LR and was closer to SS diameter for 2 #’s AP and 4#’s LR.

20# rescan group: Mean RD was larger than the control (both directions) for 15 timepoints (SS, pCT and CBCTs) and >4cm in at least 1 direction for 12. CBCT RD was more similar to pCT than SS for all bar 1# AP and 3#’s LR.



Conclusion

For patients breaching RD thresholds on SS, mean RD was reduced on rescan pCT, however reduction (including all measuring points) was <4mm in both directions.  A trend for these patients to sustain a larger rectum throughout treatment was seen, suggesting rescanning may be of limited use. Especially so for 6# patients where mean RD on CBCT was more akin to the rejected SS. This finding may be indicative of the 6# patient group, they are often older with more co-morbidities, both factors known to influence rectal filling.